4A. HIV&AIDS Invited Speaker Session: Clinical Management: HIV Co-infection Updates: Hepatitis B, Tuberculosis (TB) and Cryptococcus
Tracks
| Monday, September 14, 2026 |
| 4:00 PM - 5:30 PM |
Details
This session will provide an update on issues relating to HIV co-infections with Hepatitis B, TuberculosisB and Cryptococcus.
To provide an update on recent advances in Hepatitis B, Tuberculosis, and Cryptococcosis management in the HIV context.
Learning Objectives:
- To understand management issues unique to HIV/Hepatitis B co-infection.
- To understand management issues unique to HIV/TB co-infection.
- To understand management issues unique to HIV/Cryptococcus co-infection.
Speaker
Dr Kasha Singh
Doctor
Vids
HIV/Hepatitis B co-infection
4:00 PM - 4:30 PMBiography
Kasha completed a PhD looking at liver disease pathogenesis in HIV-hepatitis B with the Lewin lab in collaboration with the Maini lab in the UK. She is a clinician at RMH and Peninsula health with ongoing interests in HIV coinfections including hepatitis B and tuberculosis.
Dr Philipp du Cros
Infectious Diseases Specialist
Monash Health
HIV/Tuberculosis co-infection
4:30 PM - 5:00 PMBiography
Dr Philipp du Cros is a Principal Research Fellow at the Burnet Institute, and infectious diseases physician at Monash Health and leads the WHO TB/ drug-resistant Pacific regional TB advice desk. His research focuses on drug-resistant TB treatment, TB elimination strategies and treatment support.
Dr Christina Chang
Infectious Diseases Physician, NHMRC Early Career Researcher
Alfred Hospital, Monash University
HIV/Cryptococcus co-infection
5:00 PM - 5:30 PMBiography
Session Chair
David Griffin
Infectious Diseases Physician
Alfred Health
Mina John
Consultant Immunologist
Royal Perth Hospital
